You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Polo-Like Kinase 4 inhibitors/antagonists

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung

Unknown status
  • Non-Small Cell Lung Cancer
  • Tissue Collection
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Jan 28, 2021

Acute Myeloid Leukemia, MDS, Chronic Myelomonocytic Leukemia Trial in Canada, United States (CFI-400945, Azacitidine,

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Duarte, California
  • +7 more
Jul 20, 2022

Small-cell Lung Cancer, Small Cell Lung Carcinoma Trial in Pittsburgh (Onvansertib)

Recruiting
  • Small-cell Lung Cancer
  • Small Cell Lung Carcinoma
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jul 29, 2022

Liposarcoma, Osteogenic Sarcoma, Ewing/Ewing-like Sarcoma Trial in United States (Regorafenib, Placebo)

Completed
  • Liposarcoma
  • +4 more
  • Duarte, California
  • +17 more
Oct 25, 2022

MDD Trial in Shibeen Elkom (Roflumilast 250Mcg Tab, Placebo)

Recruiting
  • Major Depressive Disorder
  • Roflumilast 500Mcg Tab
  • Placebo
  • Shibeen Elkom, Menoufia, Egypt
    Faculty of Pharmacy
Jan 16, 2023

BTK Inhibitors-related AF Treated by Catheter Ablation

Not yet recruiting
  • BTKi-induced Atrial Fibrillation
  • +2 more
  • Atrial fibrillation catheter ablation in a population of BTKi-induced atrial fibrillation
  • Caen, Normandy, France
    Caen University Hospital
Nov 10, 2023

B Acute Lymphoblastic Leukemia Trial (procedure, biological, drug, radiation)

Not yet recruiting
  • B Acute Lymphoblastic Leukemia
  • Biospecimen Collection
  • +19 more
  • (no location specified)
Nov 8, 2023

Non Small Cell Lung Cancer, Liquid Biopsy, Tyrosine Kinase Inhibitor Trial in Rotterdam

Recruiting
  • Non Small Cell Lung Cancer
  • +2 more
    • Rotterdam, Netherlands
      Erasmus MC
    Feb 2, 2022

    Cyclin-dependent Kinase 4/6 Inhibitors on Body Composition in

    Recruiting
    • Breast Cancer
    • CT scans
    • DEXA scan
    • Bronx, New York
      Montefiore Medical Center
    Jan 6, 2023

    Axial Spondyloarthritis Trial in Dhaka (Baricitinib 2mg, Tofacitinib 5 mg)

    Recruiting
    • Axial Spondyloarthritis
    • Baricitinib 2mg
    • Tofacitinib 5 mg
    • Dhaka, Bangladesh
      Bangabandhu Sheikh Mujib Medical University
    Nov 1, 2023

    SGLT-2 Inhibitors in the Treatment of Ascites

    Recruiting
    • Ascites Hepatic
    • +2 more
    • SGLT2 inhibitor
    • Palermo, Italy
    • +1 more
    Aug 11, 2023

    Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    Aug 24, 2022

    Breast Cancer Stage IV Trial in Mansoura (comparing both arms as regard the objective response rate, toxicity profile, quality

    Recruiting
    • Breast Cancer Stage IV
    • comparing both arms as regard the objective response rate, toxicity profile, quality of life, progression free survival
    • Mansoura, Dakahlia, Egypt
      Oncology center mansoura university
    Jan 1, 2023

    Metastatic Breast Cancer, Advanced Breast Cancer, Quality of Life Trial in Worldwide (CDK 4/6 inhibitors, Endocrine therapy)

    Not yet recruiting
    • Metastatic Breast Cancer
    • +4 more
    • CDK 4/6 inhibitors
    • Endocrine therapy
    • Helsinki, Finland
    • +11 more
    Sep 19, 2023

    Shoulder Injuries Trial in Ankara (Thrower's Ten Exercise Program)

    Completed
    • Shoulder Injuries
    • Thrower's Ten Exercise Program
    • Ankara, Çankaya, Turkey
      Baskent University
    Jul 6, 2023

    Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Worldwide (procedure, other, drug)

    Recruiting
    • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • Biospecimen Collection
    • +4 more
    • Birmingham, Alabama
    • +170 more
    Jan 30, 2023

    Bile Acids in Acute Insulin Resistance

    Recruiting
    • PI3K Gene Mutation
    • +4 more
    • Drug-induced acute insulin resistance due to PI3K inhibitor, AKT inhibitor, or mTOR inhibitor
    • New York, New York
      Columbia University Medical Center
    Oct 6, 2022

    Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

    Not yet recruiting
    • Liver Transplant; Complications
    • +3 more
    • multi-kinase inhibitors in combination with bevacizumab
    • Beijing, Beijing, China
      Chinese Academy of Medical Sciences & Peking Union Medical Colle
    Sep 11, 2023

    Cancer Trial in Changsha (Protein Kinase Inhibitor)

    Recruiting
    • Cancer
    • Protein Kinase Inhibitor
    • Changsha, Hunan, China
      Central South University
    Jun 23, 2022

    Breast Cancer Trial (Abemaciclib, Letrozole)

    Not yet recruiting
    • Breast Cancer
    • (no location specified)
    Nov 14, 2023

    Hepatocellular Carcinoma Trial in Chicago (Atezolizumab and Bevacizumab, Y90 + TKI)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Atezolizumab and Bevacizumab
    • Y90 + TKI
    • Chicago, Illinois
      Northwestern University
    Nov 11, 2022

    Atopic Dermatitis Trial in Netherlands

    Recruiting
    • Atopic Dermatitis
      • Leeuwarden, Friesland, Netherlands
      • +13 more
      May 18, 2022

      Stress Ulcer Drugs and Clinical Outcomes in Acute Anterior

      Not yet recruiting
      • Acute Ischemic Stroke
        • Fuzhou, Fujian, China
        • +18 more
        Apr 26, 2023

        Heart Failure, Heart Failure With Reduced Ejection Fraction Trial in Danville (Pharmacist co-management, CDS, Focused Education)

        Recruiting
        • Heart Failure
        • Heart Failure With Reduced Ejection Fraction
        • Pharmacist co-management
        • +2 more
        • Danville, Pennsylvania
          Geisinger Cardiology Clinics
        Aug 11, 2023

        Tumors, Kidney Tumors, Urologic Tumors Trial in Nanjing (Toripalimab, Axitinib, Lenvatinib)

        Recruiting
        • Neoplasms
        • +12 more
        • Nanjing, Jiangsu, China
          Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
        Oct 28, 2023